RhoU基因沉默对破骨细胞分化的影响

doi:10.11843/j.issn.0366-6964.2019.09.019

Abstract

Abstract: In order to study the effect of RhoU (Wrch1) in osteoclast (OC) differentiation, we used RAW 264.7 cells (mononuclear macrophage cell line) as the basis for transfection of negative lentivirus and siRhoU lentivirus and established stable cell lines. In the presence of macrophage colony-stimulating factor (M-CSF) and nuclear factor-κB receptor activating factor ligand (RANKL), the negative control group and the RhoU-silencing group were induced for 3 or 4 days, respectively. The expression of RhoU and osteoclast-specific protein and its mRNA was detected by Western blot and quantitative polymerase chain reaction (qRT-PCR), respectively. The formation of osteoclasts was observed by tartrate acid phosphatase (TRAP) staining. The morphology of osteoclasts and their precursor cells was observed by confocal laser scanning microscope. The results showed that compared with the negative control group, the RhoU gene mRNA and protein expression in the RhoU-silencing group was significantly decreased (P<0.01).The number and area formation of osteoclasts were significantly decreased (P<0.01). The formation of filopodia in osteoclast precursor cells was blocked and it lacked complete sealing zone. The expression of osteoclast-specific gene mRNA and protein was significantly decreased (P<0.01 or P<0.05), while the TRAP gene mRNA was not changed (P>0.05). In conclusion, silencing RhoU can inhibit the differentiation of osteoclasts, inhibiting the formation of filamentous pseudopods in precursor cells and affecting their fusion may be the main mechanism.

CLC Number:

ZHENG Jiaming, HE Shuangjiang, ZHAO Hongyan, SONG Ruilong, LIU Zongping. Effect of RhoU Silencing on Osteoclast Differentiation[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2019, 50(9): 1904-1911.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://www.xmsyxb.com/EN/10.11843/j.issn.0366-6964.2019.09.019

https://www.xmsyxb.com/EN/Y2019/V50/I9/1904

References

[1] VAANANEN H K, LAITALA-LEINONEN T. Osteoclast lineage and function[J]. Arch Biochem Biophys, 2008, 473(2):132-138.
[2] INDO Y, TAKESHITA S, ISHⅡ K A, et al. Metabolic regulation of osteoclast differentiation and function[J]. J Bone Miner Res, 2013, 28(11):2392-2399.
[3] ONO T, NAKASHIMA T. Recent advances in osteoclast biology[J]. Histochem Cell Biol, 2018, 149(4):325-341.
[4] BOYLE W J, SIMONET W S, LACEY D L. Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937):337-342.
[5] ZACH F, POLZER F, MUELLER A, et al. p62/sequestosome 1 deficiency accelerates osteoclastogenesis in vitro and leads to Paget's disease-like bone phenotypes in mice[J]. J Biol Chem, 2018, 293(24):9530-9541.
[6] JANSEN I D C, VERMEER J A F, BLOEMEN V, et al. Osteoclast fusion and fission[J]. Calcified Tissue Int, 2012, 90(6):515-522.
[7] CHEN X, WANG Z Q, DUAN N, et al. Osteoblast-osteoclast interactions[J]. Connect Tissue Res, 2018, 59(2):99-107.
[8] 左志慧, 胡江天. 细胞骨架生物力学的研究进展[J]. 医学综述, 2013, 19(19):3457-3459.
ZUO Z H, HU J T. Research advances in cytoskeletal biomechanics[J]. Medical Recapitulate, 2013, 19(19):3457-3459. (in Chinese)
[9] BRAZIER H, PAWLAK G, VIVES V, et al. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration[J]. Int J Biochem Cell Biol, 2009, 41(6):1391-1401.
[10] 赵龙,陈彻,李明,等. 艰难梭菌毒素A对K562细胞Rho GTPases及细胞骨架的影响[J]. 中国实验血液学杂志, 2018, 26(5):1330-1335.
ZHAO L, CHEN C, LI M, et al. Effects of Tcd A on Rho GTPases and the cytoskeleton of leukemia cell line K562[J]. Journal of Experimental Hematology, 2018, 26(5):1330-1335. (in Chinese)
[11] DRUBIN D G, MAZZORANA M, TERRADO J, et al. Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts[J]. Mol Biol Cell, 2014, 25(3):380-396.
[12] TAO W K, PENNICA D, XU L F, et al. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1[J]. Gene Dev, 2001, 15(14):1796-1807.
[13] SONG R L, LIU X Z, ZHU J Q, et al. New roles of filopodia and podosomes in the differentiation and fusion process of osteoclasts[J]. Genet Mol Res, 2014, 13(3):4776-4787.
[14] 宋瑞龙. OPG对破骨细胞分化过程中细胞骨架的影响及其分子机理[D]. 扬州:扬州大学, 2014.
SONG R L. Influences of osteoprotegerin on the cytoskeleton of osteoclast and the involve signalling pathways in the process of osteoclast differentiation[D]. Yangzhou:Yangzhou University, 2014. (in Chinese)
[15] VÄÄNÄNEN H K, ZHAO H B, MULARI M, et al. The cell biology of osteoclast function[J]. J Cell Sci, 2000, 113:377-381.
[16] MATSUBARA T, KINBARA M, MAEDA T, et al. Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin[J]. Biochem Biophys Res Commun, 2017, 489(4):472-476.
[17] ZHANG D, UDAGAWA N, NAKAMURA I, et al. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts[J]. J Cell Sci, 1995, 108:2285-2292.
[18] ORY S, BRAZIER H, BLANGY A. Identification of a bipartite focal adhesion localization signal in RhoU/Wrch-1, a Rho family GTPase that regulates cell adhesion and migration[J]. Biol Cell, 2007, 99(12):701-716.
[19] DIEPENHORST N A, NOWELL C J, RUEDA P, et al. High throughput, quantitative analysis of human osteoclast differentiation and activity[J]. Anal Biochem, 2017, 519:51-56.
[20] LU J, WANG M L, WANG Z Y, et al. Advances in the discovery of cathepsin K inhibitors on bone resorption[J]. J Enzyme Inhib Med Chem, 2018, 33(1):890-904.
[21] DODDS R A, JAMES I E, RIEMAN D, et al. Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption[J]. J Bone Mineral Res, 2001, 16(3):478-486.
[22] FUNAYAMA H, ISHIKAWA S E, KUBO N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction[J]. Circ J, 2004, 68(5):451-454.
[23] WANG X D, YU Y Y, LIEU S, et al. MMP9 regulates the cellular response to inflammation after skeletal injury[J]. Bone, 2013, 52(1):111-119.
[24] BERNHARDT A, KOPERSKI K, SCHUMACHER M, et al. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays[J]. Eur Cells Mater, 2017, 33:28-42.
[25] KIN J H, KIM E Y, LEE B, et al. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264. 7 cells[J]. Int J Mol Med, 2016, 37(3):649-658.
[26] DESTAING O, SALTEL F, GÉMINARD J C, et al. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein[J]. Mol Biol Cell, 2003, 14(2):407-416.
[27] BATSIR S, GEIGER B, KAM Z. Dynamics of the sealing zone in cultured osteoclasts[J]. Cytoskeleton, 2017, 74(2):72-81.
[28] JURDIC P, SALTEL F, CHABADEL A, et al. Podosome and sealing zone:specificity of the osteoclast model[J]. Eur J Cell Biol, 2006, 85(3-4):195-202.
[29] TAKITO J, INOUE S, NAKAMURA M. The sealing zone in osteoclasts:a self-organized structure on the bone[J]. Int J Mol Sci, 2018, 19(4):984.
[30] XU S, ZHANG Y, WANG J, et al. TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42[J]. Cell Death Differ, 2018, 25(9):1549-1566.

Effect of RhoU Silencing on Osteoclast Differentiation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments